<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.

Stroke and Ischemia Models

SPEAK WITH A SCIENTIST

mdbiosciences-neurology-leading-preclinical-CRO-1

Advancing Preclinical Research with Stroke and Ischemia Models

MD Biosciences provides well-characterized stroke models for translational stroke research, including MCAO stroke models in rodents (permanent and transient) and global ischemia models (4VO). Our stroke models closely replicate human ischemic injury, offering essential insights into neurodegeneration, neuroinflammation, and therapeutic efficacy. By leveraging these animal models of ischemic stroke, researchers can generate robust preclinical data to accelerate the development of effective stroke interventions.

Speak with a scientist
 
Scientific Data

Diversity in Stroke Models

The figure shows grip test results in the MCAo stroke model, revealing significant differences between young and aged males, as well as between aged males and aged females.

Assessments

MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.

behavior

Behavior 

Conduct extensive pain, sensory, motor, and cognitive behavioral testing.

biomarker

Biomarkers

Explore inflammatory and pain biomarkers in disease-specific tissues.

histology

Histology

Characterize tissue and cellular changes in disease, pain, and neurodegeneration.

READY TO DISCUSS YOUR PROGRAM?

MD Biosciences is your dedicated partner in drug development, offering tailored study designs, translational models, and comprehensive endpoints. With short lead times, competitive pricing, and deep scientific expertise, we help move your pipeline forward efficiently.

Request Proposal